## Abstract ## BACKGROUND The objectives of this prospective study were to avoid adjuvant treatment for patients with intraocular disease and patients with postlaminar optic nerve invasion (PLβONI) without full choroidal or scleral invasion. Adjuvant chemotherapy (Regimen 1) was given to patients
Stage-related combined modality treatment of retinoblastoma. Results of a prospective study
β Scribed by Cathryn Howarth; David Meyer; H. Omar Hustu; Warren W. Johnson; Ellen Shanks; Charles Pratt
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 780 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
During 4 years, 51 patients with retinoblastoma were studied (unilateral 32, and bilateral 19). Treatment consisted of enucleation of those eyes which showed massive involvement followed by radiotherapy when there was optic nerve and/or orbit involvement. Systemic chemotherapy was administered to al
Seventy-two patients with retinoblastoma (RTB) (unilateral (47 patients] and bilateral [25 patients]) were studied for a period of 6 years. Treatment consisted of enucleation of those eyes that had severe involvement and was followed by radiation therapy and/or chemotherapy (systemic or intrathecal)
## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twiceβdaily radiotherapy (BIDRT) or onceβdaily radiotherapy (QDRT) resulted in a better outcome for patients with limitedβst